cefuroxime eg 500 mg filmomh. tabl.
eg sa-nv - cefuroximeaxetil 601,44 mg - eq. cefuroxim 500 mg - filmomhulde tablet - 500 mg - cefuroximeaxetil 601.44 mg - cefuroxime
cefuroxime eg 500 mg compr. pellic.
eg sa-nv - céfuroxime axétil 601,44 mg - eq. céfuroxime 500 mg - comprimé pelliculé - 500 mg - céfuroxime axétil 601.44 mg - cefuroxime
cefuroxime stravencon 250 mg sol. perf. (pdr.) i.m./i.v. flac.
stravencon ltd. - céfuroxime sodique - eq. céfuroxime 250 mg - poudre pour solution pour perfusion - 250 mg - céfuroxime sodique - cefuroxime
cefuroxime stravencon 750 mg sol. perf. (pdr.) i.m./i.v. flac.
stravencon ltd. - céfuroxime sodique - eq. céfuroxime 750 mg - poudre pour solution pour perfusion - 750 mg - céfuroxime sodique - cefuroxime
cefuroxime stravencon 1500 mg sol. inj./perf. (pdr.) i.m./i.v. flac.
stravencon ltd. - céfuroxime sodique - eq. céfuroxime 1500 mg - poudre pour solution injectable/pour perfusion - 1500 mg - céfuroxime sodique - cefuroxime
cefuroxime 250 mg powder for solution for injection
stravencon ltd - cefuroxime sodium - powder for solution for injection - 250 milligram(s) - second-generation cephalosporins; cefuroxime
cefuroxime 750 mg powder for solution for injection
stravencon ltd - cefuroxime sodium - powder for solution for injection - 750 milligram(s) - second-generation cephalosporins; cefuroxime
cefuroxime 1500 mg powder for solution for injection or infusion
stravencon ltd - cefuroxime sodium - powder for solution for injection/infusion - 1500 milligram(s) - second-generation cephalosporins; cefuroxime
cefuroxime 1.5 g powder for solution for injection/infusion
fresenius kabi deutschland gmbh - cefuroxime sodium - powder for solution for injection/infusion - 1.5 gram(s) - second-generation cephalosporins; cefuroxime
cefuroxime sodium injection, powder, for solution
sagent pharmaceuticals - cefuroxime sodium (unii: r8a7m9my61) (cefuroxime - unii:o1r9fj93ed) - cefuroxime for injection, usp is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: - lower respiratory tract infections , including pneumonia, caused by streptococcus pneumoniae, haemophilus influenzae (including ampicillin-resistant strains), klebsiella spp., staphylococcus aureus (penicillinase- and non-penicillinase- producing strains), streptococcus pyogenes , and escherichia coli . - urinary tract infections caused by escherichia coli and klebsiella spp. - skin and skin-structure infections caused by staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), streptococcus pyogenes , escherichia coli, klebsiella spp., and enterobacter spp. - septicemia caused by staphylococcus aureus (penicillinase- and non-penicillinase- producing strains), streptococcus pneumoniae, escherichia coli, haemophilus influenzae (including ampicillin-resistant strains), and klebsiella spp. - men